Power Law company profile

Cytek

Biotech & Life Sciences · Fremont, United States · Founded 1992 · IPO 2021 Thoroughbred

A leading manufacturer and supplier of flow cytometry products and services

Valuation

$350M

Market cap · May/2026

Revenue

$201M

Latest reported FY

EBITDA

$2.0M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

7 investors on Cytek's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

F-Prime

Series B+ 6 investors entered at this stage

3E Bioventures

Hillhouse Capital

OrbiMed

NLVC

LYFE Capital

RA Capital Management

Global footprint

Where Cytek has talent and traffic

AI talent share

1.4% of workforce is AI talent
(6 of 443 staff)

Core AI30.68%

Other AI30.68%

Non-AI workforce43798.65%

Workforce by country

26 countries with
team presence

🇺🇸 United States66.1%

🇨🇳 China6.3%

🇳🇱 Netherlands5.5%

🇫🇷 France3.4%

🇩🇪 Germany3%

Top 5 of 26 shown

Web traffic by country

70K monthly visits
across markets

🇺🇸 United States37%

🇨🇦 Canada6.9%

🇬🇧 United Kingdom6.4%

🇸🇪 Sweden6.1%

🇳🇱 Netherlands5%

Top 5 markets shown

Market sentiment

What the market is saying about Cytek

An AI-synthesized read of the highest-engagement posts about Cytek on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cytek on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles